Patents Assigned to Laplace Interventional Inc.
  • Patent number: 12569338
    Abstract: Devices used to deploy transvascular medical device systems and methods for using such devices are described in this document. For example, this document describes dilating introducer devices used for the percutaneous vascular deployment of catheter-based medical devices such as structural heart medical devices. Such dilating introducer devices can facilitate the percutaneous vascular deployment of catheter-based medical devices without an additional introducer sheath.
    Type: Grant
    Filed: March 27, 2024
    Date of Patent: March 10, 2026
    Assignee: Laplace Interventional Inc.
    Inventors: Nathaniel Thomas Smith, Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 12440333
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: April 3, 2025
    Date of Patent: October 14, 2025
    Assignee: Laplace Interventional Inc.
    Inventors: Lucas Tradd Schneider, Gunnar Paul Askegaard, Ramji Iyer
  • Patent number: 12440336
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valves are implanted using catheter-based deployment systems that include multiple control wires. In particular implementations, the deployment systems can include a retrieval catheter that can be used to recapture the prosthetic heart valve back into a delivery sheath after being expressed from the delivery sheath. The prosthetic heart valves can include a plurality of optional suture knots to enhance migration resistance. Some delivery catheter systems can include a controllably bendable control catheter and/or a deflectable catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: March 20, 2025
    Date of Patent: October 14, 2025
    Assignee: Laplace Interventional Inc.
    Inventors: Rachel Jean Anderson, Lucas Tradd Schneider, Gunnar Paul Askegaard, Daniel Oliver, Ramji Iyer
  • Patent number: 12376963
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valves are implanted using catheter-based deployment systems that include multiple control wires. In particular implementations, the deployment systems can include a retrieval catheter that can be used to recapture the prosthetic heart valve back into a delivery sheath after being expressed from the delivery sheath. The prosthetic heart valves can include a plurality of optional suture knots to enhance migration resistance. Some delivery catheter systems can include a controllably bendable control catheter and/or a deflectable catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: May 9, 2025
    Date of Patent: August 5, 2025
    Assignee: Laplace Interventional Inc.
    Inventors: Rachel Jean Anderson, Lucas Tradd Schneider, Gunnar Paul Askegaard, Daniel Oliver, Ramji Iyer
  • Patent number: 12279953
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.
    Type: Grant
    Filed: July 10, 2024
    Date of Patent: April 22, 2025
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard
  • Patent number: 12279951
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to the targeted heart valve site via a delivery catheter. In some embodiments, the heart valve replacement system can assemble a valve device after the valve device is delivered to the heart. In some embodiments, heart valve replacement system includes two anterior flaps that are separate but overlap each other.
    Type: Grant
    Filed: May 25, 2023
    Date of Patent: April 22, 2025
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Stephen Anderson, Samuel Thomas Johnson
  • Patent number: 12144726
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: February 2, 2024
    Date of Patent: November 19, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 12064349
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valves are implanted using catheter-based deployment systems that include multiple control wires. In particular implementations, the deployment systems can include a retrieval catheter that can be used to recapture the prosthetic heart valve back into a delivery sheath after being expressed from the delivery sheath. The prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved control catheter and/or a deflectable catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: October 30, 2023
    Date of Patent: August 20, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard, Brett R. Olsen, Rachel Jean Anderson
  • Patent number: 12059346
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.
    Type: Grant
    Filed: January 31, 2024
    Date of Patent: August 13, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard
  • Patent number: 11969188
    Abstract: Devices used to deploy transvascular medical device systems and methods for using such devices are described in this document. For example, this document describes dilating introducer devices used for the percutaneous vascular deployment of catheter-based medical devices such as structural heart medical devices. Such dilating introducer devices can facilitate the percutaneous vascular deployment of catheter-based medical devices without an additional introducer sheath.
    Type: Grant
    Filed: September 18, 2023
    Date of Patent: April 30, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Nathaniel Thomas Smith, Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 11918460
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: September 8, 2023
    Date of Patent: March 5, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 11918463
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.
    Type: Grant
    Filed: April 17, 2023
    Date of Patent: March 5, 2024
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard
  • Patent number: 11806235
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile; thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment o the prosthetic heart valve to a native tricuspid valve site via a superior vena cave or inferior vena cave.
    Type: Grant
    Filed: March 16, 2023
    Date of Patent: November 7, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 11759316
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: March 22, 2023
    Date of Patent: September 19, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 11712336
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: August 1, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Lucas Tradd Schneider, Gunnar Paul Askegaard, Ramji Iyer
  • Patent number: 11701223
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to the targeted heart valve site via a delivery catheter. In some embodiments, the heart valve replacement system can assemble a valve device after the valve device is delivered to the heart. In some embodiments, heart valve replacement system includes two anterior flaps that are separate but overlap each other.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: July 18, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Stephen Anderson, Samuel Thomas Johnson
  • Patent number: 11672655
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.
    Type: Grant
    Filed: November 23, 2022
    Date of Patent: June 13, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard
  • Patent number: 11638643
    Abstract: Prosthetic heart valves may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, the prosthetic heart valve includes structural features that securely anchor the prosthetic heart valve to the anatomy at the site of the native heart valve. Such structural features can provide robust migration resistance. In addition, the prosthetic heart valves can include structural features that improve sealing between the prosthetic valve and native valve anatomy to mitigate paravalvular leakage. In particular implementations, the prosthetic heart valves occupy a small delivery profile, thereby facilitating a smaller delivery catheter system for advancement to the heart. Some delivery catheter systems can include a curved inner catheter to facilitate deployment of the prosthetic heart valve to a native tricuspid valve site via a superior vena cava or inferior vena cava.
    Type: Grant
    Filed: November 14, 2022
    Date of Patent: May 2, 2023
    Assignee: Laplace Interventional Inc.
    Inventors: Gunnar Paul Askegaard, Lucas Tradd Schneider, Ramji Iyer
  • Patent number: 11510777
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to a targeted native heart valve site via one or more delivery catheters. In some embodiments, a prosthetic heart valve of the system includes structural features that securely anchor the prosthetic heart valve to the site of the native heart valve. Such structural features can provide robust migration resistance. In particular implementations, the prosthetic heart valves occupy a smaller delivery profile, thereby facilitating a smaller delivery catheter for advancement to the heart.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: November 29, 2022
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Lucas Tradd Schneider, Gunnar Paul Askegaard
  • Patent number: 11337801
    Abstract: Some embodiments described herein include a heart valve replacement system that may be delivered to the targeted heart valve site via a delivery catheter. In some embodiments, the heart valve replacement system can assemble a valve device after the valve device is delivered to the heart. In some embodiments, heart valve replacement system includes two anterior flaps that are separate but overlap each other.
    Type: Grant
    Filed: September 2, 2021
    Date of Patent: May 24, 2022
    Assignee: Laplace Interventional Inc.
    Inventors: Ramji Iyer, Stephen Anderson, Samuel Thomas Johnson